These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6329628)

  • 1. Molecular dosimetry techniques in human risk assessment: an industrial perspective.
    Wright AS
    Dev Toxicol Environ Sci; 1983; 11():311-8. PubMed ID: 6329628
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunochemical and GC/MS analysis of protein adducts: dosimetry studies with ethylene oxide.
    Britton DW; Törnqvist M; van Sittert NJ; Watson WP; Wraith MJ; Wright AS
    Prog Clin Biol Res; 1991; 372():99-106. PubMed ID: 1956952
    [No Abstract]   [Full Text] [Related]  

  • 3. Analogous patterns of benzo[a]pyrene metabolism in human and rodent cells.
    Selkirk JK
    Carcinog Compr Surv; 1985; 10():123-33. PubMed ID: 4064001
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring and risk assessment by means of alkyl groups in hemoglobin in persons occupationally exposed to ethylene oxide.
    Calleman CJ; Ehrenberg L; Jansson B; Osterman-Golkar S; Segerbäck D; Svensson K; Wachtmeister CA
    J Environ Pathol Toxicol; 1978; 2(2):427-42. PubMed ID: 739221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fluorometric-HPLC assay for quantitating the binding of benzo[a]pyrene metabolites to DNA.
    Rahn RO; Chang SS; Holland JM; Shugart LR
    Biochem Biophys Res Commun; 1982 Nov; 109(1):262-8. PubMed ID: 6297478
    [No Abstract]   [Full Text] [Related]  

  • 6. Tissue doses in man: implications in risk assessment.
    Golkar SO
    Dev Toxicol Environ Sci; 1983; 11():289-98. PubMed ID: 6677463
    [No Abstract]   [Full Text] [Related]  

  • 7. A new approach for measuring protein adducts from benzo[a]pyrene diolepoxide by high performance liquid chromatography/tandem mass spectrometry.
    Helleberg H; Törnqvist M
    Rapid Commun Mass Spectrom; 2000; 14(18):1644-53. PubMed ID: 10962485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of L-ascorbate of binding to DNA of benzo(a)pyrene & its metabolites.
    Shah GM; Bhattacharya RK
    Indian J Biochem Biophys; 1980 Apr; 17(2):96-8. PubMed ID: 7450799
    [No Abstract]   [Full Text] [Related]  

  • 9. Carcinogen-metabolizing enzymes and susceptibility to chemical carcinogenesis.
    Bartsch H; Aitio A; Camus AM; Malaveille C; Roberfroid M; Vo Thi KO; Sabadie N
    IARC Sci Publ; 1983; (51):147-56. PubMed ID: 6321342
    [No Abstract]   [Full Text] [Related]  

  • 10. Absorption and disposition of MeIQx in man: lessons for human dosimetry.
    Boobis AR; Gooderham NJ; Murray BP; Murray S; Lynch A; Sesardic D; Davies DS
    Prog Clin Biol Res; 1991; 372():89-98. PubMed ID: 1956951
    [No Abstract]   [Full Text] [Related]  

  • 11. Benzo(a)pyrene-DNA adduct formation and removal in mouse epidermis in vivo and in vitro: relationship of DNA binding to initiation of skin carcinogenesis.
    Nakayama J; Yuspa SH; Poirier MC
    Cancer Res; 1984 Sep; 44(9):4087-95. PubMed ID: 6331664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1.
    Kushman ME; Kabler SL; Fleming MH; Ravoori S; Gupta RC; Doehmer J; Morrow CS; Townsend AJ
    Carcinogenesis; 2007 Jan; 28(1):207-14. PubMed ID: 16885195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of mutagenic glucuronide formation from benzo(a)pyrene in the nonrecirculating perfused rat liver.
    Kari FW; Kauffman FC; Thurman RG
    Cancer Res; 1984 Nov; 44(11):5073-8. PubMed ID: 6488167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
    Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
    Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and macromolecular binding of carcinogenic and noncarcinogenic metabolites of benzo(a)pyrene by hamster embryo cells.
    Cohen GM; MacLeod MC; Moore CJ; Selkirk JK
    Cancer Res; 1980 Feb; 40(2):207-11. PubMed ID: 7356503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of benzo(a)pyrene:DNA adducts formed in cells in culture by immobilized boronate chromatography.
    Pruess-Schwartz D; Sebti SM; Gilham PT; Baird WM
    Cancer Res; 1984 Sep; 44(9):4104-10. PubMed ID: 6331665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunoassay for monitoring human exposure to ethylene oxide.
    Wraith MJ; Watson WP; Eadsforth CV; van Sittert NJ; Törnqvist M; Wright AS
    IARC Sci Publ; 1988; (89):271-4. PubMed ID: 3198209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent complexes of DNA and two stereoisomers of benzo(a)pyrene 7,8-dihydrodiol-9,10-epoxide studied by fluorescence and linear dichroism.
    Undeman O; Lycksell PO; Gräslund A; Astlind T; Ehrenberg A; Jernström B; Tjerneld F; Nordén B
    Cancer Res; 1983 Apr; 43(4):1851-60. PubMed ID: 6403229
    [No Abstract]   [Full Text] [Related]  

  • 19. Biomonitoring of chemicals and their metabolites.
    van Sittert NJ
    IARC Sci Publ; 1984; (59):153-72. PubMed ID: 6545278
    [No Abstract]   [Full Text] [Related]  

  • 20. Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: cancer potency estimates for ethylene oxide.
    Kirman CR; Sweeney LM; Teta MJ; Sielken RL; Valdez-Flores C; Albertini RJ; Gargas ML
    Risk Anal; 2004 Oct; 24(5):1165-83. PubMed ID: 15563286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.